SLC29A2 and cancer: The DNA-binding capability of 3E10 is critical for its ability to penetrate cells and nuclei [22], a process that relies on equilibrative nucleoside transporter 2 (ENT2) [21, 23–25], which is more abundantly expressed in cancer cells than in healthy tissues [26].